Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 3, 2020
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
Mon, March 2, 2020
[ Mon, Mar 02nd 2020
] - WOPRAI
Ed Arce Initiated (AKRO) at Strong Buy and Held Target at $33 on, Mar 2nd, 2020
Ed Arce of HC Wainwright & Co., Initiated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $33 on, Mar 2nd, 2020.
Ed has made no other calls on AKRO in the last 4 months.
There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $36 on, Monday, February 10th, 2020
Similar Stocks and Investing Articles
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Fri, May 11th 2018
] - WOPRAI
[ Mon, Mar 19th 2018
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Mar 07th 2017
] - WOPRAI
[ Mon, Dec 19th 2016
] - WOPRAI